Journal
OPEN FORUM INFECTIOUS DISEASES
Volume 7, Issue 12, Pages -Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofaa575
Keywords
coronavirus disease 2019; COVID-19; antibiotics; prescriptions; outpatient; United States
Categories
Ask authors/readers for more resources
In April 2020, there were significant reductions in prescription fills of each of the 10 most prescribed outpatient antibiotics in the United States. Monthly azithromycin, amoxicillin-clavulanate, and levofloxacin fills did not rebound significantly from April through July 2020. Coronavirus disease 2019 had an immediate and sustained impact on US outpatient antibiotic prescribing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
